RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $13,000 | -40.9% | 2,259 | 0.0% | 0.00% | – |
| Q4 2021 | $22,000 | -46.3% | 2,259 | 0.0% | 0.00% | – |
| Q3 2021 | $41,000 | -25.5% | 2,259 | 0.0% | 0.00% | – |
| Q2 2021 | $55,000 | -6.8% | 2,259 | 0.0% | 0.00% | – |
| Q1 2021 | $59,000 | +247.1% | 2,259 | 0.0% | 0.00% | – |
| Q4 2020 | $17,000 | +54.5% | 2,259 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | -15.4% | 2,259 | 0.0% | 0.00% | – |
| Q2 2020 | $13,000 | +30.0% | 2,259 | 0.0% | 0.00% | – |
| Q1 2020 | $10,000 | -52.4% | 2,259 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | -68.7% | 2,259 | -46.9% | 0.00% | – |
| Q2 2019 | $67,000 | – | 4,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |